ScreenerHero
MPTMedical Properties Trust Inc. common stock
NYSE · US · Real Estate · REIT - Healthcare Facilities · medicalpropertiestrust.com
4.100USD-1.44%Mkt Cap: 2.48B $P/E: —

Medical Properties Trust, Inc. is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception, the Company has grown to become one of the world's l…

Industry Peers

REIT - Healthcare Facilities
Screen all
WELL
Welltower Inc.
$169.86BUSDP/E 105.2
VTR
Ventas, Inc.
$47.11BUSDP/E 167.0
OHI
Omega Healthcare Investors, Inc.
$14.80BUSDP/E 16.7
DOC
Healthpeak Properties, Inc.
$14.72BUSDP/E 59.3
CTRE
CareTrust REIT, Inc.
$9.41BUSDP/E 24.9
HR
Healthcare Realty Trust Incorporated
$6.78BUSD
AED
Aedifica SA
$6.17BUSDP/E 5.9
SBRA
Sabra Health Care REIT, Inc.
$5.25BUSDP/E 79.0
CSH-UN
Chartwell Retirement Residences
$5.06BUSDP/E 1054.0
NHI
National Health Investors, Inc.
$3.64BUSDP/E 21.4
PHP
Primary Health Properties PLC
$3.17BUSDP/E 15.9
LTC
LTC Properties, Inc.
$2.17BUSDP/E 14.4
DHC
Diversified Healthcare Trust
$1.96BUSD
SILA
Sila Realty Trust Inc. Common Stock
$1.68BUSDP/E 44.6
STRW
Strawberry Fields REIT Inc. Common Stock
$769.23MUSDP/E 20.9
NHP
National Healthcare Properties Inc. Class A Common Stock
$747.36MUSD
CPINV
Care Property Invest
$563.33MUSDP/E 8.1
UHT
Universal Health Realty Income Trust
$571.24MUSDP/E 29.6
XRN
Chiron Real Estate Inc. Common Stock
$533.88MUSDP/E 9.9
CHCT
Community Healthcare Trust Incorporated
$422.58MUSDP/E 22.1

Key Statistics

Company
Market Cap2.48B $
Enterprise Value11.75B $
Revenue (TTM)1.10B $
Gross Profit935.61M $
Net Income (TTM)-277.05M $
Revenue/Share1.843 USD
Last Price4.100 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees121
CountryUS
SectorReal Estate
IndustryREIT - Healthcare Facilities
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)37.09
PEG1.61
EV/EBITDA12.38
EV/Revenue10.63
P/S2.21
P/B0.54
EPS (TTM)-0.05
EPS (Forward)0.11
52W Range
3.9904% of range6.470
52W High6.470 USD
52W Low3.990 USD
Profitability
Gross Margin96.25%
Oper. Margin57.36%
EBITDA Margin85.87%
Profit Margin-28.50%
ROE-6.01%
ROA-1.85%
Growth
Revenue Growth1.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF230.77M $
CapEx (TTM)—
FCF Margin68.24%
FCF Yield30.35%
Net Debt9.31B $
Net Debt/EBITDA9.81
Balance Sheet
Debt/Equity2.13
Current Ratio1.17
Quick Ratio1.00
Book Value/Sh7.538 USD
Cash/Share0.6640 USD
Dividends
Fwd Div Rate0.3600 USD
Trail. Div Rate0.3500 USD
Div. Yield8.65%
5Y Avg Yield10.13%
Payout Ratio1054.55%
Ex-Div DateSep 10, 2026
Pay DateOct 8, 2026
Analyst Consensus
Rating3.1 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)5.107 USD
Upside (mean)+24.6%
Target Range4.250 USD – 7.000 USD
$4.250+24.6% to mean$7.000
# Analysts7
Ownership
Shares Out.597.20M
Float489.75M
Insiders17.55%
Institutions62.87%
Short Interest
Short Ratio27.0d
Short % Float32.36%
Short % Out.24.18%
Shares Short144.27M
Short (prev mo.)138.11M
Technical
SMA 504.573 (-10.3%)
SMA 2005.009 (-18.1%)
Beta1.46
S&P 52W Chg18.16%
Avg Vol (30d)6.13M
Avg Vol (10d)10.46M
Technical Indicators
RSI (14)37.7
MACD-0.1624
MACD Signal-0.1138
MACD Hist.-0.0486
BB Upper5.120 USD
BB Middle4.508 USD
BB Lower3.895 USD
BB Width27.17%
ATR (14)0.1585 USD
Vol Ratio (20d)1.11x